Baff Binds to the Tumor Necrosis Factor Receptor–Like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell Population

The tumor necrosis factor (TNF) family member B cell activating factor (BAFF) binds B cells and enhances B cell receptor–triggered proliferation. We find that B cell maturation antigen (BCMA), a predicted member of the TNF receptor family expressed primarily in mature B cells, is a receptor for BAFF. Although BCMA was previously localized to the Golgi apparatus, BCMA was found to be expressed on the surface of transfected cells and tonsillar B cells. A soluble form of BCMA, which inhibited the binding of BAFF to a B cell line, induced a dramatic decrease in the number of peripheral B cells when administered in vivo. Moreover, culturing splenic cells in the presence of BAFF increased survival of a percentage of the B cells. These results are consistent with a role for BAFF in maintaining homeostasis of the B cell population.

[1]  Don Foster,et al.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease , 2000, Nature.

[2]  J. Tschopp,et al.  Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations , 1999, The Journal of experimental medicine.

[3]  D. Stuart,et al.  Structure of the TRAIL–DR5 complex reveals mechanisms conferring specificity in apoptotic initiation , 1999, Nature Structural Biology.

[4]  M. Ultsch,et al.  Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. , 1999, Molecular cell.

[5]  E. Lefèvre,et al.  Cutting edge: HIV-1 Tat protein differentially modulates the B cell response of naive, memory, and germinal center B cells. , 1999, Journal of immunology.

[6]  Amy S Orr,et al.  BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. , 1999, Science.

[7]  J. Tschopp,et al.  BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth , 1999, The Journal of experimental medicine.

[8]  B. Aggarwal,et al.  Identification and Characterization of a Novel Cytokine, THANK, aTNF Homologue That ActivatesApoptosis, Nuclear Factor-κB, and c-Jun NH2-Terminal Kinase* , 1999, The Journal of Biological Chemistry.

[9]  S. Pillai,et al.  The chosen few? Positive selection and the generation of naive B lymphocytes. , 1999, Immunity.

[10]  H. Shu,et al.  TALL‐1 is a novel member of the TNF family that is down‐regulated by mitogens , 1999, Journal of leukocyte biology.

[11]  J. Borst,et al.  Tumor necrosis factor receptor family members in the immune system. , 1998, Seminars in immunology.

[12]  R. Berger,et al.  The characterization of murine BCMA gene defines it as a new member of the tumor necrosis factor receptor superfamily. , 1998, International immunology.

[13]  J P Luzio,et al.  Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. , 1998, Science.

[14]  F. Mackay,et al.  Lymph Node Genesis Is Induced by Signaling through the Lymphotoxin β Receptor , 1998 .

[15]  S R Sprang,et al.  Modularity in the TNF-receptor family. , 1998, Trends in biochemical sciences.

[16]  A. Basten,et al.  Influences on the lifespan of B cell subpopulations defined by different phenotypes , 1997, European journal of immunology.

[17]  F. Agenès,et al.  Independent homeostatic regulation of B cell compartments , 1997, European journal of immunology.

[18]  J. Tschopp,et al.  Characterization of two receptors for TRAIL. , 1997, FEBS letters.

[19]  J. Rigaut,et al.  BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes. , 1995, International immunology.

[20]  C. Ware,et al.  A lymphotoxin-beta-specific receptor. , 1994, Science.

[21]  R. Berger,et al.  The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed. , 1994, Nucleic acids research.

[22]  D. Kioussis,et al.  Mechanism of lymphocyte function-associated molecule 3-Ig fusion proteins inhibition of T cell responses. Structure/function analysis in vitro and in human CD2 transgenic mice. , 1994, Journal of immunology.

[23]  S. Bixler,et al.  Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses , 1993, The Journal of experimental medicine.

[24]  D. Banner,et al.  Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation , 1993, Cell.

[25]  R Berger,et al.  A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma. , 1992, The EMBO journal.